天津医药 ›› 2022, Vol. 50 ›› Issue (2): 155-159.doi: 10.11958/20211208

• 实验研究 • 上一篇    下一篇

天麻素可改善多发性抽动症模型大鼠的头部抽动行为

代卫锋,韩雪,岳姣姣,葛国岚
  

  1. 1郑州大学附属儿童医院中医科(邮编450018);2河南省人民医院血液科

  • 收稿日期:2021-05-21 修回日期:2021-09-23 出版日期:2022-02-15 发布日期:2022-02-15
  • 通讯作者: 代卫锋 E-mail:dwf870502@163.com
  • 作者简介:基金新,属卫健委下;统计见二修
  • 基金资助:
    2020年度河南省医学科技攻关计划联合共建项目(LHGJ20200667

Gastrodin can improve the head twitch behavior of rats with Tourette syndrome

DAI Weifeng, HAN Xue, YUE Jiaojiao, GE Guolan #br#   

  1. 1 Department of Traditional Chinese Medicine, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou 450018,
    China; 2 Department of Hematology, Henan Provincial People's Hospital

  • Received:2021-05-21 Revised:2021-09-23 Published:2022-02-15 Online:2022-02-15

摘要: 目的 探讨天麻素对多发性抽动症(TS)模型大鼠头部抽动行为的影响及相关机制。方法 采用1-(2,5- 二甲氧基-4-碘苯基)-2-氨基丙烷(DOI)诱导法制备TS大鼠模型,将40只Wistar大鼠随机均分为4组:正常组(生理 盐水灌胃)、TS模型组(从造模首日起,注射DOI后2 h以生理盐水灌胃)、TS+天麻素组(从造模首日起,注射DOI后2 h以 30 mg/kg天麻素灌胃);TS+天麻素+CHIR-99021[糖原合酶激酶-3β(GSK-3β)抑制剂]组(从造模首日起,注射DOI后 2 h,先以2 mg/kg CHIR-99021腹腔注射,再以30 mg/kg天麻素灌胃),连续给药21 d。末次给药后,记录大鼠在30 min 内的头部抽动次数,采用试剂盒检测纹状体5-羟色胺(5-HT)、5-羟吲哚乙酸(5-HIAA)、多巴胺(DA)水平,免疫组化 法检测黑质中 DA 神经元数量,Western blot 法检测纹状体中 5-羟色胺转运蛋白(SERT)、5-羟色胺 2A 受体(5- HT2AR)、5-羟色胺2C受体(5-HT2CR)表达及GSK-3β磷酸化情况。结果 与正常组比较,TS模型组大鼠头部抽动 次数、DA 水平、DA 神经元数量、SERT 水平及 p-S9-GSK-3β、p-S9-GSK-3β/t-GSK-3β 水平增高,5-HT 水平降低 (P<0.05)。与TS模型组比较,TS+天麻素组大鼠头部抽动次数、DA水平、DA神经元数量、SERT水平及p-S9-GSK- 3β、p-S9-GSK-3β/t-GSK-3β水平降低,5-HT水平升高(P<0.05)。与TS+天麻素组比较,TS+天麻素+CHIR-99021 组大鼠头部抽动次数、DA水平、DA神经元数量、SERT水平及p-S9-GSK-3β、p-S9-GSK-3β/t-GSK-3β水平升高,5- HT水平降低(P<0.05)。结论 天麻素可改善TS大鼠头部抽动行为,其作用机制可能是通过抑制GSK-3β的磷酸 化,调节SERT表达,影响5-HT水平,进而抑制纹状体中DA的释放。

关键词: 天麻甙, 糖原合成酶激酶-3β, 血清素, 多巴胺, 受体, 血清素, 5-HT2A, 受体, 血清素, 5-HT2C, 多发性抽动症, 5-羟色胺转运蛋白

Abstract: Objective To investigate the effect and mechanism of gastrodin on head twitch behavior in rats with Tourette syndrome (TS). Methods 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane (DOI) induction method was used to replicate TS rat model. Forty Wistar rats were randomly divided into four groups (n=10): the normal group (gastric administration of normal saline), the TS model group (from the first day of modeling, intragastric administration with normal saline at 2 h after DOI injection), the TS+ gastrodin group (from the first day of modeling, intragastric administration with 30 mg/kg gastrodin at 2 h after DOI injection), and the TS+gastrodin+CHIR-99021 group [glycogen synthase kinase-3β (GSK- 3β) inhibitor] (from the first day of modeling, 2 h after DOI injection, intraperitoneal injection with 2 mg/kg CHIR-99021 firstly, and then intragastric administration with 30 mg/kg gastrodin), continuous administration for 21 d. After the last administration, the rat’s head twitching behavior within 30 min was counted. The levels of striatal 5-hydroxyindole (5-HT), 5-hydroxyindole acetic acid (5-HIAA), and dopamine (DA) were detected by kits. The number of DA neurons in the substantia nigra was detected by immunohistochemical method. The expression of 5-HT transporter (SERT), 5- hydroxyindole 2A receptor (5-HT2AR), 5-hydroxyindole 2C receptor (5-HT2CR) and GSK-3β phosphorylation in the striatum were detected by Western blot assay. Results Compared with the normal group, the number of head twitches, DA level, number of DA neurons, SERT level and p-S9-GSK-3β, p-S9-GSK-3β/t-GSK-3β level increased in the TS model group, and the 5-HT level decreased (P<0.05). Compared with the TS model group, the number of head twitches, DA level, number of DA neurons, SERT level and p-S9-GSK-3β, p-S9-GSK-3β/t-GSK-3β level decreased in the TS+gastrodin group, and the 5-HT level increased (P<0.05). Compared with the TS+gastrodin group, the number of head twitches, DA level, number of DA neurons, SERT level and p-S9-GSK-3β, p-S9-GSK-3β/t-GSK-3β level increased , and the 5-HT level decreased in the TS+gastrodin+CHIR-99021 group (P<0.05). Conclusion Gastrodin can improve the head twitch behavior of TS rats, and its mechanism may be by inhibiting the phosphorylation of GSK-3β, regulating the expression of SERT, affecting the level of 5-HT, and then inhibiting the release of DA in striatum.

Key words: gastrodin, glycogen synthase kinase 3 beta, serotonin, dopamine, receptor, serotonin, 5-HT2A, receptor, serotonin, 5-HT2C, Tourette syndrome, 5-hydroxytryptamine transporter